Hextend (6% hetastarch in lactated electrolyte) / Lineage Cell Therap, Pfizer, Korea Kolmar  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hextend (6% hetastarch in lactated electrolyte) / Korea Kolmar, Pfizer, Lineage Cell Therap
NCT00307138: Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery

Completed
3
330
US
hetastarch
Kaiser Permanente, Kaiser Foundation Research Institute
Postoperative Hemorrhage
 
08/05

Download Options